Gossamer Bio, Inc. (NASDAQ:GOSS) Q1 2026 Earnings Call Transcript May 18, 2026
Gossamer Bio, Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.17.
Operator: Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Gossamer Bio Q1 2026 Earnings Call. [Operator Instructions] It is now my pleasure to turn the call over to Bryan Giraudo, Chief Operating Officer and Chief...
